ECDC announcement
A new modelling study from RespiCompass, the ECDC Respiratory Diseases Scenario Modelling Hub, indicates that influenza and COVID-19 vaccination programmes markedly reduced hospitalisations among older adults across Europe in the 2024/25 season.
Despite these vaccines being proven to prevent severe illness, influenza vaccination rates in most EU/EEA countries remain below the World Health Organization targets for at-risk groups, and COVID-19 vaccination rates continue to fall.
Read the full announcement here.
Access the ECDC report, Multi-model analysis to quantify the impact of vaccination on COVID-19 and influenza hospitalisation burden among older adults in the EU/EEA, 2024/25, here.
Source : ECDC
Related HIV and Co-Infections News
-
SHIELD: Multi-million-euro project to prevent infections from developing into cancer
-
WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service
-
One dose of either a bivalent or nonavalent HPV vaccine provides protection against HPV16 or HPV18 infection and is not inferior to two doses
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.